UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000050700 |
|---|---|
| Receipt number | R000057758 |
| Scientific Title | Measurement of opioid sensitivity by sympathetic response evoking threshold during sevoflurane anesthesia. |
| Date of disclosure of the study information | 2023/04/01 |
| Last modified on | 2023/03/28 14:43:14 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Measurement of opioid sensitivity by sympathetic response evoking threshold during sevoflurane anesthesia.
Acronym
Measurement of opioid sensitivity by sympathetic response evoking threshold during sevoflurane anesthesia.
Scientific Title
Measurement of opioid sensitivity by sympathetic response evoking threshold during sevoflurane anesthesia.
Scientific Title:Acronym
Measurement of opioid sensitivity by sympathetic response evoking threshold during sevoflurane anesthesia.
Region
| Japan |
Condition
Condition
Elective surgery patient over 18 years old
Classification by specialty
| Anesthesiology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
The validation for new index(MECK) using sympathetic response can be a indicator of the rate of change of systolic blood pressure (ROCBP) before and after skin incision during remimazolam anesthesia
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Correlation coefficient between MECK and ROCBP
Key secondary outcomes
goodness of fit of the prediction equation for ROCBP by MECK under propofol administration in the previous study to the data of this study
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Adult patients who under go open surgery which require invasive blood pressure measurement during remimazolam anesthesia.
Patients who are informed enough and presents the will of participation to this study by written form.
Key exclusion criteria
Patients with irregular R-R intervals on the electrocardiogram.
Patients who cannot measure invasive blood pressure in the radial artery.
Patients with severe blood circulation or neuropathy in the upper limbs.
Patients with severe stenosis or obstructive lesions of coronary arteries and cerebrovascular disease.
Patients with contraindicated use of remifentanil or rocuronium.
Target sample size
30
Research contact person
Name of lead principal investigator
| 1st name | Saeki |
| Middle name | |
| Last name | Noboru |
Organization
Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University
Division name
Department of Anesthesiology and Critical Care
Zip code
734-8551
Address
1-2-3,Kasumi,Minami-ku,Hiroshima
TEL
81-082-327-5267
nsaeki@hiroshima-u.ac.jp
Public contact
Name of contact person
| 1st name | Ayaka |
| Middle name | |
| Last name | Ishibashi |
Organization
Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University
Division name
Department of Anesthesiology and Critical Care
Zip code
734-8551
Address
1-2-3,Kasumi,Minami-ku,Hiroshima
TEL
81-082-256-5267
Homepage URL
ayakaishibashi1217@gmail.com
Sponsor or person
Institute
Department of Anesthesiology and Critical Care, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University
Institute
Department
Personal name
Funding Source
Organization
None
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Ethical Committee of Hiroshima University
Address
1-2-3,Kasumi,Minami-ku,Hiroshima
Tel
81-082-257-5907
iryo-seisaku@office.hiroshima-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2023 | Year | 04 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2023 | Year | 02 | Month | 03 | Day |
Date of IRB
| 2023 | Year | 02 | Month | 03 | Day |
Anticipated trial start date
| 2023 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Measure MECK and the rate of change of systolic blood pressure before and after skin incision under remimazolam and remifentanil 2ng/ml anesthesia.
Management information
Registered date
| 2023 | Year | 03 | Month | 28 | Day |
Last modified on
| 2023 | Year | 03 | Month | 28 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057758
